GlassScriptPhysician profile
Rachel Garrison
NPI 1033624523
$4,944.03
in general payments reported to CMS, 2019-2025
50 companies · $972 in 2025
The $972 reported for 2025 was more than what 83% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,414 · 2022: $955 · 2023: $933 · 2024: $671 · 2025: $972.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,575.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,575.12 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $727.49 | 2021-2025 | Breztri, Farxiga, Airsupra |
| Janssen Pharmaceuticals, INC | $443.42 | 2021-2025 | Spravato |
| Abbvie INC. | $341.14 | 2021-2025 | |
| Novo Nordisk INC | $319.19 | 2022-2025 | Ozempic, Wegovy, Rybelsus |
| Lilly USA, LLC | $263.62 | 2022-2025 | Jardiance, Zepbound, Mounjaro |
| Kowa Pharmaceuticals America, INC. | $261.25 | 2021-2022 | |
| Amgen INC. | $214.97 | 2021-2025 | Repatha, Otezla, Evenity |
| Glaxosmithkline, LLC. | $214.61 | 2022-2025 | Trelegy Ellipta, Shingrix, Arexvy |
| Teva Pharmaceuticals USA, INC. | $203.30 | 2024-2025 | Austedo Xr, Austedo Xr, Ajovy |
| Abbott Laboratories | $186.83 | 2021-2025 | Freestyle Libre 3 |
| Amarin Pharma, INC. | $164.32 | 2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $135.26 | 2022-2025 | |
| Corium, LLC | $125.59 | 2022-2024 | Azstarys |
| Pfizer INC. | $122.47 | 2022-2025 | |
| Takeda Pharmaceuticals U.S.A., INC. | $115.22 | 2022-2025 | Trintellix |
Show all 50 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Rachel Garrison listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.